BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 19031029)

  • 1. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
    van Kooten C; Stax AS; Woltman AM; Gelderman KA
    Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-generated DC with tolerogenic functions: perspectives for in vivo cellular therapy.
    van Kooten C; Gelderman KA
    Methods Mol Biol; 2011; 677():149-59. PubMed ID: 20941608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of rapamycin in the induction of tolerogenic dendritic cells.
    Fischer R; Turnquist HR; Taner T; Thomson AW
    Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulatory role of dendritic cells in the immune tolerance.
    Li YP; Latger-Canard V; Marchal L; Li N; Ou-Yang JP; Stoltz JF
    Biomed Mater Eng; 2006; 16(4 Suppl):S163-70. PubMed ID: 16823108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and the induction of tolerance by dendritic cells.
    Buckland M; Lombardi G
    Handb Exp Pharmacol; 2009; (188):197-213. PubMed ID: 19031027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs.
    Hackstein H; Thomson AW
    Nat Rev Immunol; 2004 Jan; 4(1):24-34. PubMed ID: 14704765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.
    Turnquist HR; Thomson AW
    Curr Opin Organ Transplant; 2008 Aug; 13(4):350-7. PubMed ID: 18685329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel findings in drug-induced dendritic cell tolerogenicity.
    Svajger U; Obermajer N; Jeras M
    Int Rev Immunol; 2010 Dec; 29(6):574-607. PubMed ID: 21073328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.
    Adorini L; Giarratana N; Penna G
    Semin Immunol; 2004 Apr; 16(2):127-34. PubMed ID: 15036236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory dendritic cell therapy in organ transplantation.
    McCurry KR; Colvin BL; Zahorchak AF; Thomson AW
    Transpl Int; 2006 Jul; 19(7):525-38. PubMed ID: 16764631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation.
    Turnquist HR; Fischer RT; Thomson AW
    Methods Mol Biol; 2010; 595():135-48. PubMed ID: 19941109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new phenotype of tolerogenic human dendritic cells induced by fungal proteases from Aspergillus oryzae.
    Zimmer A; Luce S; Gaignier F; Nony E; Naveau M; Biola-Vidamment A; Pallardy M; Van Overtvelt L; Mascarell L; Moingeon P
    J Immunol; 2011 Apr; 186(7):3966-76. PubMed ID: 21368225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies.
    Franchimont D
    Ann N Y Acad Sci; 2004 Jun; 1024():124-37. PubMed ID: 15265777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.
    Rutella S; Lemoli RM
    Immunol Lett; 2004 Jun; 94(1-2):11-26. PubMed ID: 15234530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells in transplant tolerance.
    Nouri-Shirazi M
    Iran J Immunol; 2007 Mar; 4(1):1-14. PubMed ID: 17652838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
    Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
    Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effect of quercetin on dendritic cell activation and function.
    Huang RY; Yu YL; Cheng WC; OuYang CN; Fu E; Chu CL
    J Immunol; 2010 Jun; 184(12):6815-21. PubMed ID: 20483746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.